CVM GFI #263 Recommendations for Sponsors of Medically Important Antimicrobial Drugs Approved for Use in Animals to Voluntarily Bring Under Veterinary Oversight All Products That Continue to be Available Over-the-Counter
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 11, 2021
June 10, 2021
407951dd-51f8-47fc-ab03-daf135a661a4
Related Documents
CVM GFI #267 Biomarkers and Surrogate Endpoints in Clinical Studies to Support Effectiveness of New Animal Drugs
Guidance DocumentOctober 6, 2021Center for Veterinary Medicine
CVM GFI #255 Elemental Impurities in Animal Drug Products Questions and Answers
Guidance DocumentNovember 23, 2020Center for Veterinary Medicine
CVM GFI #240 Proprietary Names for New Animal Drugs
Guidance DocumentJune 1, 2020Center for Veterinary Medicine
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.